![]() ![]() |
|
||||||||||||||||
| A special project of the Michigan Diabetes Outreach Network |
|||||||||||||||||
| Chapter
6 Insulin Insulin is used in type 2 diabetes when blood glucose (BG) levels exceed 126 mg/dl fasting or exceed 200 mg/dl postprandial after trying meal planning, activity, and weight loss. Some may need to be started on insulin immediately, especially if they have unexplained weight loss and severe hyperglycemia. Hyperinsulinemia The theoretical disadvantage of hyperinsulinemia from using insulin injections does not outweigh the proven benefits of glycemic control. Starting insulin
Doses can be increased 2-5 units every 3-4 days, depending on blood glucose levels. Some may need over 100 units of insulin per day to control blood glucose. Adjunct Therapies for Type 2 Diabetes Exanatide (Byetta)
Pramlintide acetate is administered by subcutaneous injection prior to meals to mimic normal levels. Injection technique is the same as that for insulin. It cannot be mixed with insulin and may require pre-meal insulin be reduced to prevent hypoglycemia. Side effects may include nausea, vomiting, dizziness, indigestion, stomach pain, decreased appetite and fatigue. Its use is contraindicated in those with gastroparesis, hypoglycemia unawareness, women who are pregnant or breastfeeding and children. Vials in use can be stored at room temperature (less than 77°F) for 28 days and then discarded. Vials not in use should be stored in the refrigerator and discarded after the expiration date. |
|||||||||||||||||
| |
|||||||||||||||||
|
|||||||||||||||||